Registry for patients with coronary microvascular disease
Official title: Coronary Microvascular Disease (CMD) Registry
Run by Medstar Health Research Institute · NCT05960474 · Data updated 2026-11-12
This study is creating a database to collect information from people with coronary microvascular disease to help researchers learn more about the condition and improve treatments.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Medstar Health Research Institute Academic / other |
| Locations | 3 sites (Washington D.C., District of Columbia and 2 other locations) |
| Status | Recruiting |
| Started | February 1, 2023 |
| Main results expected | January 2033 |
| Study ends | January 2033 |
| Registry record updated | June 7, 2024 |
| Trial ID | NCT05960474 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this registry are individuals diagnosed with coronary microvascular disease.
✕Probably not a fit
Patients without a diagnosis of coronary microvascular disease are unlikely to benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project aims to create a comprehensive database for patients diagnosed with coronary microvascular disease (CMD). It will involve the systematic collection and storage of patient data, which will be used for research purposes to better understand CMD. The registry will facilitate data sharing and collaboration among researchers to enhance knowledge and treatment options for this condition.
Why it matters
Potential benefit: If successful, this registry could lead to improved understanding and management of coronary microvascular disease, ultimately benefiting patients through better treatment strategies.
How similar studies have gone: While this approach is observational and may not have direct precedents, registries for similar cardiovascular conditions have shown success in advancing research and treatment.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Those with Coronary Microvascular Disease
Where it's running
-
Medstar Washington Hospital Center
Washington D.C., District of Columbia, United States Recruiting -
Memorial Regional Hospital
Hollywood, Florida, United States Recruiting -
MedStar Southern Maryland
Clinton, Maryland, United States Recruiting
Study contacts
- Study coordinator: Kassandra Lopez
- Email: kassandra.lopez@medstar.net
- Phone: 202-877-2452
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Coronary thrombus modification to reduce microvascular damage during STEMI care
This study tests whether modifying the clot in the heart arteries during primary PCI can lessen microvascular damage and myocardial injury in STEMI patients.
-
CS reducer device for symptomatic HFpEF with coronary microvascular dysfunction
This study will test whether implanting a coronary sinus (CS) reducer reduces heart muscle ischemia on stress CMR in adults with HFpEF and coronary microvascular dysfunction.
-
Improving coronary blood flow in women with HIV and diabetes or chronic kidney disease
This study will test whether referring women with HIV and diabetes or chronic kidney disease to a specialist so they can be considered for SGLT2 inhibitor medicine, compared with health education alone, improves blood flow in their hearts.
-
Measuring heart microvascular function in heart attack patients
This study is testing how well the tiny blood vessels in the heart work in people who have had a heart attack to see how treatment affects their recovery.
-
Effects of Tirzepatide on Heart Health in Overweight Individuals
This study tests if tirzepatide can improve heart health and reduce plaque in the arteries of overweight people with stable coronary artery disease.
-
Registry of patients with angina undergoing coronary physiology testing
This study collects information from adults with angina to see how well different tests for heart issues work and what happens to patients over time.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.